Incannex Healthcare (IXHL) Earnings Date & Reports

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IXHL is expected to report earnings to rise 371.43% to -66 cents per share on November 13

Incannex Healthcare IXHL Stock Earnings Reports

Q3'26

Est.

$-0.66

Q2'26

Missed

by $0.27

Q1'26

Beat

by $70.74

Q4'25

Beat

by $67.98

Q2'25

Beat

by $67.62

The last earnings report on September 25 showed earnings per share of -14 cents, missing the estimate of 12 cents. With 76.22K shares outstanding, the current market capitalization sits at 34.62M.

View a ticker or compare two or three

IXHL

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI Trading Bots for IXHL